Anzeige
❌
Mehr »
Montag, 16.11.2026 - Börsentäglich über 12.000 News
GBC-Kursziel 2,00 CAD bis Juni 2027, Kurs 0,67 CAD: Verdreifachung drin?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
AM

WKN: A14WL9 | ISIN: FR0011051598 | Ticker: A1H
Stuttgart
16.11.26 | 17:31
0,297 Euro
0,00 % 0,000
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AMOEBA Chart 1 Jahr
5-Tage-Chart
AMOEBA 5-Tage-Chart
RealtimeGeldBriefZeit
0,2920,32217:50

Aktuelle News zur AMOEBA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18:23AMOEBA: Following vineyards and vegetable crops, Amoéba and Koppert expand their partnership into orchards across Europe58Press release On 16 November 2026 Berkel en Rodenrijs, Netherlands and Chassieu, France Strengthened cooperation with Koppert, reaffirming its long-term commitment to Amoéba, to bring...
► Artikel lesen
18:22Amoeba: Following vineyards and vegetable crops, Amoéba and Koppert expand their partnership into orchards across Europe72Berkel en Rodenrijs, Netherlands and Chassieu, France, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Strengthened cooperation with Koppert, reaffirming its long-term commitment to Amoéba, to bring innovative...
► Artikel lesen
30.10.AMOEBA: Amoéba announces the publication of its half-year financial report as of June 30, 2026881Chassieu (France), 30 October 2026 - 6.00 pm - Amoéba (FR0011051598 - ALMIB), an industrial greentech company specialising in the development of natural microbiological solutions based on the patented...
► Artikel lesen
27.10.AMOEBA: Amoéba announces the successful completion of its EUR 9.7 million capital increase open to all shareholders545This press release must not be circulated, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press release does...
► Artikel lesen
20.10.AMOEBA: Reminder regarding the warrants (BSA) attached to the capital increase through the issuance of ABSAs open to all shareholders598This press release must not be circulated, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press release does...
► Artikel lesen
06.10.XFRA CAPITAL ADJUSTMENT INFORMATION - 06.10.2026339Das Instrument 2QO US74736K1016 QORVO INC.DL -,0001 EQUITY wird ex Kapitalmassnahme gehandelt am 06.10.2026 The instrument 2QO US74736K1016 QORVO INC.DL -,0001 EQUITY is traded ex capital adjustment...
► Artikel lesen
02.10.AMOEBA: Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch4.708Press release This press release must not be circulated, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
25.09.AMOEBA: Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency870Press Release This press release may not be released, published, or distributed, directly or indirectly, in or into the United States of America, Canada, Australia, or Japan. This press...
► Artikel lesen
AMOEBA Aktie jetzt für 0€ handeln
24.09.AMOEBA: Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency791Press Release This press release may not be released, published, or distributed, directly or indirectly, in or into the United States of America, Canada, Australia, or Japan. This press...
► Artikel lesen
24.09.AMOEBA: Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset974Amoéba completed its transition into an industrial and commercial company in biocontrol in H1 2026, with the delivery of its first biocontrol orders; Provisional H1 2026 financial...
► Artikel lesen
10.09.Amoeba: Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen1.111Basel, Schweiz, und Chassieu, Frankreich, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Die exklusive Vereinbarung umfasst den Getreidemarkt in der Europäischen Union, im Vereinigten Königreich, in der Ukraine...
► Artikel lesen
08.09.AMOEBA: Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers1.241The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market launches from 2028/29; This new-generation biocontrol...
► Artikel lesen
23.07.AMOEBA: Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides991Chassieu (France), 23 July 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, and its partner Koppert, world...
► Artikel lesen
30.06.AMOEBA: Amoéba has received marketing authorization in France for its biofungicide AXPERA951Chassieu (France), 30 June 2026 - 07:30 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
08.06.AMOEBA: Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew892Chassieu (France), 8 June 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
06.05.AMOEBA: Two new exceptional trial permits in the Netherlands in 2026 for Amoéba's biocontrol solution1.362Amoéba and Koppert have each been granted special authorization to use AXPERA technology on a wide range of crops These exemptions include food crops for consumption. Chassieu (France), 6...
► Artikel lesen
28.04.AMOEBA: Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards837Chassieu (France), 28 April 2026 - 6:00 p.m. - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has received...
► Artikel lesen
13.04.AMOEBA: Amoéba and Koppert highlight the potential of AXPERA technology in Brazil for strategic crops822Chassieu (France), 13 April 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
26.03.AMOEBA: Amoéba announces the success of its capital increase and raises EUR 6.67 million1.658Chassieu (France), 26 March 2026 - 8:00 a.m. - Amoéba (FR0011051598 - ALMIB ), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
25.03.AMOEBA: Amoéba strengthens its financial visibility to support its industrial and commercial expansion1.823Press release This press release must not be released, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1